Exenatide is a synthetic peptide incretin mimetic that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control in patients with type 2 diabetes. By activating these… Read more













Exenatide is a synthetic peptide incretin mimetic that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control in patients with type 2 diabetes. By activating these receptors, the drug enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying. This category includes high-quality reference standards for exenatide, covering the active pharmaceutical ingredient (API), as well as related impurities and degradation products such as acetylated forms and various amino acid substituted derivatives. Additionally, stable isotope labelled compounds like exenatide-d5 are available to support rigorous analytical testing. These reference materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and ongoing quality control, ensuring the accuracy and sensitivity required for monitoring complex peptide synthesis and stability during drug development.